Boston Partners’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-77,003
| Closed | -$199K | – | 732 |
|
|
2023
Q1 | $199K | Hold |
77,003
| – | – | ﹤0.01% | 674 |
|
|
2022
Q4 | $143K | Hold |
77,003
| – | – | ﹤0.01% | 678 |
|
|
2022
Q3 | $142K | Buy |
77,003
+847
| +1% | +$1.56K | ﹤0.01% | 686 |
|
|
2022
Q2 | $164K | Sell |
76,156
-8,105
| -10% | -$17.5K | ﹤0.01% | 676 |
|
|
2022
Q1 | $265K | Hold |
84,261
| – | – | ﹤0.01% | 663 |
|
|
2021
Q4 | $270K | Buy |
+84,261
| New | +$270K | ﹤0.01% | 650 |
|